Elevance Raises Full-Year Guidance on Lower Medical Costs
Published . Updated .
Elevance raises full-year guidance on lower medical costs Modern Healthcare
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
Price reaction, T-5 to T+3
Elevance raises full-year guidance on lower medical costs Modern Healthcare
Source: Modern Healthcare
How solid “Elevance Raises Full-Year Guidance on Lower Medical Costs” looks
25 out of 100
“Elevance Raises Full-Year Guidance on Lower Medical Costs” scores 25 out of 100. The score uses 2 sources.